Neuroone Medical Technologies Corp (NMTC) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.23x

Neuroone Medical Technologies Corp (NMTC) has a Cash Flow Reinvestment Rate of 0.23x as of December 2024, reinvesting $48.83K (capex $24.42K plus investments $-24.42K) from operating cash flow of $208.05K. Check Neuroone Medical Technologies Corp cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.23x
(Capex + Investments) / Operating CF

Total Reinvested

$48.83K
Capex + Investments

Operating Cash Flow

$208.05K
USD

Capital Expenditures

$24.42K
USD

Neuroone Medical Technologies Corp Cash Flow Reinvestment Rate (2009–2009)

Historical reinvestment intensity for Neuroone Medical Technologies Corp across 1 annual periods. Explore Neuroone Medical Technologies Corp debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Neuroone Medical Technologies Corp (2009–2009)

Year-by-year capital reinvestment analysis for Neuroone Medical Technologies Corp. For live market cap and broader valuation context, see Neuroone Medical Technologies Corp (NMTC) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2009 0.00x $0.00 $6.18K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow